World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
46
Citations
8059
World Ranking
4623
National Ranking
2082

Overview

Igor M. Belyakov is affiliated with the University of Michigan-Ann Arbor in the United States. Their research spans several fields primarily within medicine and biochemistry, genetics, and molecular biology. The scientist's work encompasses subfields such as biotechnology, infectious diseases, emergency medicine, molecular biology, and management of technology and innovation.

Their publication record includes research on SARS-CoV-2 and COVID-19, studies on intramuscular injections and their effects, microbial inactivation methods, transgenic plants and applications, viral infectious diseases and gene expression in insects, economic and technological systems analysis, and Arctic and Russian policy studies.

Frequent publication venues for their work include:

  • Expert Review of Vaccines
  • Public Administration Issues
  • UNC Libraries
  • Molecular Biology
  • PubMed

The scientist has collaborated frequently with several coauthors, such as:

  • D. N. Kisakov
  • E. V. Tigeeva
  • Л. И. Карпенко
  • L.A. Kisakova
  • M. B. Borgoyakova

Notable papers authored or coauthored by Igor M. Belyakov include:

  • "The use of electroporation to deliver DNA-based vaccines," 2023, Expert Review of Vaccines
  • "ON QUANTITATIVE RISK ASSESSMENT OF INFRASTRUCTURAL PROJECTS WITH STATE PARTICIPATION," 2022, Public Administration Issues
  • "Large intestine-targeted, nanoparticle-releasing oral vaccine to control genitorectal viral infection," 2020, UNC Libraries
  • "Immunization of Mice with the pVAXrbd DNA Vaccine by Jet Injection Induces a Stronger Immune Response and Protection against SARS-CoV-2 Compared to Intramuscular Injection by Syringe," 2025, Molecular Biology
  • "[Immunization of Mice with the pVAXrbd DNA Vaccine by Jet Injection Induces a Stronger Immune Response and Protection against SARS-CoV-2 Compared to Intramuscular Injection by Syringe].," 2025, PubMed

Best Publications

  • Strategies for designing and optimizing new generation vaccines

    Jay A. Berzofsky;Jeffrey D. Ahlers;Igor M. Belyakov

  • Progress on new vaccine strategies for the immunotherapy and prevention of cancer

    Jay A. Berzofsky;Masaki Terabe;Sang Kon Oh;Igor M. Belyakov

  • Mucosal immunization with HIV-1 peptide vaccine induces mucosal and systemic cytotoxic T lymphocytes and protective immunity in mice against intrarectal recombinant HIV-vaccinia challenge

    Igor M. Belyakov;Michael A. Derby;Jeffrey D. Ahlers;Brian L. Kelsall

  • Shared modes of protection against poxvirus infection by attenuated and conventional smallpox vaccine viruses

    Igor M. Belyakov;Patricia Earl;Amiran Dzutsev;Vladimir A. Kuznetsov

  • Transcutaneous immunization induces mucosal CTLs and protective immunity by migration of primed skin dendritic cells

    Igor M. Belyakov;Scott A. Hammond;Jeffrey D. Ahlers;Gregory M. Glenn

  • Mucosal AIDS vaccine reduces disease and viral load in gut reservoir and blood after mucosal infection of macaques.

    Igor M. Belyakov;Zdenek Hel;Brian Kelsall;Vladimir A. Kuznetsov

  • What Role Does the Route of Immunization Play in the Generation of Protective Immunity against Mucosal Pathogens?

    Unknown

  • The importance of local mucosal HIV-specific CD8(+) cytotoxic T lymphocytes for resistance to mucosal viral transmission in mice and enhancement of resistance by local administration of IL-12.

    Igor M. Belyakov;Jeffrey D. Ahlers;Benjamin Y. Brandwein;Patricia Earl

  • Mucosal vaccination overcomes the barrier to recombinant vaccinia immunization caused by preexisting poxvirus immunity

    Igor M. Belyakov;Bernard Moss;Warren Strober;Jay A. Berzofsky

  • Progress on new vaccine strategies against chronic viral infections

    Jay A. Berzofsky;Jeffrey D. Ahlers;John Edward Janik;John Morris

  • Toll-like receptor ligands synergize through distinct dendritic cell pathways to induce T cell responses: Implications for vaccines

    Qing Zhu;Colt Egelston;Aravindhan Vivekanandhan;Satoshi Uematsu

  • Using 3 TLR ligands as a combination adjuvant induces qualitative changes in T cell responses needed for antiviral protection in mice.

    Qing Zhu;Colt Egelston;Susan Gagnon;Yongjun Sui

  • Large intestine-targeted, nanoparticle-releasing oral vaccine to control genitorectal viral infection

    Qing Zhu;James Talton;Guofeng Zhang;Tshaka Cunningham

  • Immunobiology of mucosal HIV infection and the basis for development of a new generation of mucosal AIDS vaccines.

    Igor M. Belyakov;Jay A. Berzofsky

  • DNA vaccines encoding human immunodeficiency virus-1 glycoprotein 120 fusions with proinflammatory chemoattractants induce systemic and mucosal immune responses.

    Arya Biragyn;Igor M. Belyakov;Yen Hung Chow;Dimiter S. Dimitrov

  • Induction of a Mucosal Cytotoxic T-Lymphocyte Response by Intrarectal Immunization with a Replication-Deficient Recombinant Vaccinia Virus Expressing Human Immunodeficiency Virus 89.6 Envelope Protein

    Igor M. Belyakov;Linda S. Wyatt;Jeffrey D. Ahlers;Patricia Earl

  • Impact of vaccine-induced mucosal high-avidity CD8+CTLs in delay of AIDS viral dissemination from mucosa

    Igor M. Belyakov;Vladimir A. Kuznetsov;Brian Kelsall;Dennis Klinman

  • A push–pull approach to maximize vaccine efficacy: Abrogating suppression with an IL-13 inhibitor while augmenting help with granulocyte/macrophage colony-stimulating factor and CD40L

    Jeffrey D. Ahlers;Igor M. Belyakov;Masaki Terabe;Rima Koka

  • Immunostimulatory DNA-Based Vaccines Elicit Multifaceted Immune Responses Against HIV at Systemic and Mucosal Sites

    Anthony A. Horner;Sandip K. Datta;Kenji Takabayashi;Igor M. Belyakov

  • Memories that last forever: strategies for optimizing vaccine T-cell memory

    Unknown

  • A novel functional CTL avidity/activity compartmentalization to the site of mucosal immunization contributes to protection of macaques against simian/human immunodeficiency viral depletion of mucosal CD4+ T cells.

    Igor M. Belyakov;Dmitry Isakov;Qing Zhu;Amiran Dzutsev

  • Approaches to improve engineered vaccines for human immunodeficiency virus and other viruses that cause chronic infections

    Berzofsky Ja;Ahlers Jd;Derby Ma;Pendleton Cd

Frequent Co-Authors

Jay A. Berzofsky
Jay A. Berzofsky National Institutes of Health
Warren Strober
Warren Strober National Institute of Allergy and Infectious Diseases
Brian L. Kelsall
Brian L. Kelsall National Institute of Allergy and Infectious Diseases
Genoveffa Franchini
Genoveffa Franchini National Institutes of Health
Bernard Moss
Bernard Moss National Institutes of Health
Masaki Terabe
Masaki Terabe National Institutes of Health
David H. Margulies
David H. Margulies National Institutes of Health
Alexander Bukreyev
Alexander Bukreyev The University of Texas Medical Branch at Galveston
Ranajit Pal
Ranajit Pal Advanced Bioscience Laboratories (United States)
David Venzon
David Venzon National Institutes of Health

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in expanding their expertise beyond Immunology, exploring related healthcare degrees can open new career opportunities. Accelerated nursing programs, such as absn programs with high acceptance rates, offer a fast track to becoming a registered nurse. These programs are ideal for individuals seeking a quicker path without compromising quality education.

LPN programs are another accessible pathway into nursing, providing foundational skills that are essential in many healthcare settings. You can find accredited lpn programs easy to get into designed to support students through a smooth admission process and comprehensive training.

For those aiming to advance further, nurse practitioner programs provide the credentials needed to deliver specialized care. Many institutions now offer nurse practitioner programs with easy admission, making it easier to pursue an advanced practice role with flexibility and support.

Specifically, for those interested in mental health, top online pmhnp programs combine convenience with excellent clinical placement rates, preparing students for impactful careers as psychiatric-mental health nurse practitioners.

Best Scientists Citing Igor M. Belyakov